<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184664</url>
  </required_header>
  <id_info>
    <org_study_id>qmul250510</org_study_id>
    <secondary_id>2010-022334-92</secondary_id>
    <nct_id>NCT01184664</nct_id>
  </id_info>
  <brief_title>Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)</brief_title>
  <acronym>CONVICT</acronym>
  <official_title>Effects of a Combination of Varenicline and Transdermal Nicotine Patch on Post-quitting Urges to Smoke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Mary University of London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen Mary University of London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Varenicline and nicotine replacement therapy (NRT) are both effective smoking cessation
      treatments. Anecdotally smokers who are finding their quit attempt difficult have reported
      benefiting from adding NRT to varenicline. This proof-of-principle placebo-controlled
      double-blind study will examine whether combining NRT and varenicline provides better
      withdrawal and craving relief than varenicline alone. A total of 120 smokers would be
      randomised to receive varenicline +15mg/16hr patch or varenicline + placebo patch. All
      participants will receive standard NHS Stop Smoking Service support. The primary outcome
      would be ratings of craving and withdrawal discomfort 24 hours and one week after the target
      quit date.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rating of urges to smoke one week after the target quit date assessed by Mood and Physical Symptoms Scale</measure>
    <time_frame>1 week</time_frame>
    <description>Rating of urges to smoke will be assessed using the Mood and Physical Symptoms Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Validated abstinence rates over weeks 1-12 post target quit date</measure>
    <time_frame>12 weeks post target quit date</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rating of withdrawal symptoms up to 4-weeks post quitting assessed by Mood and Physical Symptoms Scale</measure>
    <time_frame>4-weeks post quitting</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Profile of all adverse effects reported up to 12-weeks post quitting</measure>
    <time_frame>Up to 12-weeks post quitting</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratings of urges to smoke 24 hours after the target quit date</measure>
    <time_frame>24 hours</time_frame>
    <description>Urges to smoke at 24 hours after the target quit date will be assessed using the Mood &amp; Physical Symptoms Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Tobacco Dependence</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Varenicline + Active Patch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will use varenicline (1mg BD) + an active, 15mg/16hr Nicotine Patch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Varenicline + Placebo Patch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will use varenicline (1mg BD) + a Placebo Nicotine Patch</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Patch</intervention_name>
    <description>Varenicline + nicotine patch</description>
    <arm_group_label>Varenicline + Active Patch</arm_group_label>
    <other_name>Champix</other_name>
    <other_name>Chantix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Varenicline + placebo patch</description>
    <arm_group_label>Varenicline + Placebo Patch</arm_group_label>
    <other_name>Champix</other_name>
    <other_name>Chantix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Varenicline</intervention_name>
    <description>All participants will receive a standard dose of varenicline (12 weeks).</description>
    <arm_group_label>Varenicline + Active Patch</arm_group_label>
    <arm_group_label>Varenicline + Placebo Patch</arm_group_label>
    <other_name>Champix</other_name>
    <other_name>Chantix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Smokers seeking treatment

          -  Aged 18 and over

          -  Consenting to take part in the trial

        Exclusion Criteria:

          -  Pregnant or breastfeeding

          -  End-stage renal disease

          -  Unable to fill in questionnaires in English

          -  Previous allergy to Varenicline

          -  Previous allergy to Nicotine Patches Previous allergy to varenicline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Al-Rehan A A Dhanji, MB BS BSc MRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Mary University of London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tobacco Dependence Research and Treatment Unit</name>
      <address>
        <city>London</city>
        <zip>E1 2JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tobacco Dependence Research Unit</name>
      <address>
        <city>London</city>
        <zip>E1 2JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>October 10, 2012</last_update_submitted>
  <last_update_submitted_qc>October 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen Mary University of London</investigator_affiliation>
    <investigator_full_name>Professor Peter Hajek</investigator_full_name>
    <investigator_title>Professor of Clinical Psychology</investigator_title>
  </responsible_party>
  <keyword>Smoking cessation</keyword>
  <keyword>Tobacco dependence</keyword>
  <keyword>Varenicline</keyword>
  <keyword>Nicotine Replacement Therapy</keyword>
  <keyword>Combination therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Varenicline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

